Jatenzo v. Tlando: Similar Issues Did Not Lead To Similar Votes

 
• By Derrick Gingery

Two oral testosterone therapies solicited similar concerns, but sometimes different votes from advisory committee members on recommending approval.

FDA Advisory Committee Feature image

More from US FDA Performance Tracker

More from Regulatory Trackers